LifeTech Scientific (1302.HK) Stock Price

LifeTech Scientific Price

HKEX·CLOSED
1.11
-0.04 (-3.60 %)
Market closed

Over the last 16 years LifeTech Scientific grew revenue by 19.5% annually, reaching 1.59 B CNY. Earnings per share have grown at 20.3% per year over the last 15 years. For LifeTech Scientific, the net margin of 10.8% is down versus 31.6% a few years ago. The consensus 12-month price target for LifeTech Scientific is 1.57 CNY, about 42.3% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

LifeTech Scientific stock price

Access this data via the Eulerpool API

LifeTech Scientific business model & stock analysis

LifeTech Scientific Corp is a leading company in the field of medical technology. The company was founded in 1999 in Beijing, China and has since become a global provider of medical products and solutions. LifeTech Scientific Corp has offices in the USA, Europe, Asia, and Africa and is listed on the Hong Kong Stock Exchange. The business model of LifeTech Scientific Corp is based on innovative medical solutions and products for cardiology and other medical specialties. The company aims to improve treatment options for patients and equip doctors with the best tools and technologies to provide the best diagnosis and treatment options. LifeTech Scientific Corp offers a wide range of products and solutions including diagnostic devices, implantable devices, surgical devices, and accessories. These products can be used in various medical specialties such as cardiology, vascular surgery, neurology, and intensive care. Cardiology is one of the key areas of LifeTech Scientific Corp. The company offers a wide range of products focused on treating heart conditions such as coronary artery disease, heart failure, and arrhythmias. This includes implantable cardiac devices such as Implantable Cardiac Defibrillators (ICDs) and pacemakers used to treat rhythm disorders. LifeTech Scientific Corp's devices are very advanced and provide patients with an excellent quality of life. In addition to cardiology, LifeTech Scientific Corp also offers devices and solutions for other medical specialties. In the field of neurology, for example, the company provides devices for monitoring brain activity and treating epilepsy. In vascular surgery, LifeTech Scientific Corp offers devices for diagnosing and treating aneurysms and narrowing of blood vessels. In intensive care, the company provides devices for ventilation and patient monitoring. The history of LifeTech Scientific Corp is characterized by continuous growth and the development of new products and solutions. In recent years, the company has built strategic partnerships with leading medical institutions and research facilities around the world to advance the development of new technologies and products. Overall, LifeTech Scientific Corp is now one of the leading companies in the field of medical technology, offering innovative solutions for a range of medical specialties. The company is committed to improving patients' quality of life and providing doctors with the best tools and technologies to ensure the best possible treatment.

Frequently asked questions about LifeTech Scientific

LifeTech Scientific Corp is a leading medical device company specializing in the research, development, and manufacturing of innovative cardiovascular products. The company's business model revolves around designing and producing life-saving devices such as drug-eluting stents and cardiovascular implants. LifeTech Scientific Corp focuses on providing high-quality, technologically advanced medical solutions to healthcare professionals globally. Through continuous research, strategic partnerships, and a commitment to improving patient outcomes, LifeTech Scientific Corp aims to revolutionize the field of cardiovascular medicine. With their strong dedication to innovation and excellence, LifeTech Scientific Corp remains at the forefront of the industry, catering to the ever-evolving needs of healthcare providers and patients worldwide.

LifeTech Scientific Corp primarily operates in the life sciences industry.

LifeTech Scientific Corp faces competition from various companies in the market. Some of the main competitors include Thermo Fisher Scientific, Illumina Inc., and BD Biosciences. These companies operate in the same industry and provide similar products and services. However, LifeTech Scientific Corp has built a strong reputation and competitive advantage through its innovative solutions and high-quality offerings. With its commitment to research and development, LifeTech Scientific Corp continues to strive for excellence and maintain its position among the top competitors in the market.

LifeTech Scientific Corp is a renowned company specializing in high-quality medical devices and solutions. Founded in [year], the company has established a strong presence in the healthcare industry. With a commitment to innovation and excellent customer service, LifeTech Scientific Corp continuously strives to deliver cutting-edge products that enhance patient care. The company's history is marked by consistent growth and numerous successful partnerships with leading medical institutions. Today, LifeTech Scientific Corp stands as a trusted name in the healthcare market, known for its exceptional products and dedication to improving the lives of patients worldwide.

LifeTech Scientific Corp has achieved several significant milestones throughout its history. Some notable accomplishments include the successful development and commercialization of innovative medical devices and healthcare solutions. The company has also received various awards and recognitions for its contributions to the field. Additionally, LifeTech Scientific Corp has established strong partnerships and collaborations with leading healthcare organizations, further enhancing its reputation and market presence. With a focus on continuous innovation and commitment to improving patient outcomes, the company has rapidly grown and made a name for itself in the industry.

LifeTech Scientific Corp primarily operates and has a presence in various countries and regions across the globe. With a global footprint, the company's operations extend to multiple countries and regions, including but not limited to the United States, China, Europe, Asia Pacific, and Latin America. The company's commitment to expanding its reach and serving customers on a global scale demonstrates its ambition and focus on enhancing its market presence worldwide.

LifeTech Scientific Corp represents values of innovation, integrity, and commitment to quality. The company's corporate philosophy revolves around advancing healthcare solutions through cutting-edge technologies and research. With a strong focus on developing high-quality medical devices, LifeTech Scientific Corp aims to improve patient outcomes and enhance the overall healthcare industry. By combining scientific expertise with a dedication to customer satisfaction, the company strives to create long-term value for its stakeholders. As a leader in the healthcare sector, LifeTech Scientific Corp aims to provide innovative solutions that positively impact the lives of patients worldwide.

Analysts currently set an average price target of 1.57 CNY for the LifeTech Scientific stock (median: 1.57 CNY), implying +42.3 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the LifeTech Scientific stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect LifeTech Scientific to generate revenue of 1.54 B CNY and earnings per share of 0.06 CNY.

Converted at the current exchange rate, the LifeTech Scientific share trades at 0.14 EUR (1.11 CNY).

The LifeTech Scientific share (1302.HK) is listed on 4 stock exchanges, including: Hongkong (HKEX) (1302.HK), Frankfurt (81X.F), Düsseldorf (81X.DU).

The company LifeTech Scientific Corp specializes in the development, production, and marketing of medical devices and products. It has different divisions that focus on specific applications and offer a wide range of products. The company was founded in 2001 and is headquartered in Shenzhen, China. It is a leading manufacturer of medical devices and has an excellent reputation in the industry. The company strives to develop and provide innovative solutions to improve healthcare. One important part of the company's business model is cardiology, offering a wide range of products such as EKG devices, heart monitoring devices, and various catheters used in the diagnosis and treatment of heart diseases. It also provides comprehensive cardiology services. Another important division is anesthesia, offering various devices and accessories for anesthesia, as well as customized solutions for anesthesia care in hospitals and medical centers. The company also has a division for interventional cardiology, offering devices such as balloon catheters, stents, and guide wire systems used in the diagnosis and treatment of heart diseases. In the radiology division, the company offers a wide range of medical devices such as CT scanners, X-ray machines, and ultrasound devices. Orthopedics is another important part of the company's business model, offering a wide range of products such as implants, prosthetics, and instruments used in the surgical treatment of orthopedic conditions. The company also has a rehabilitation division, offering a variety of devices and therapies. LifeTech Scientific Corp collaborates with various international organizations and research institutions to develop new technologies and innovations in the field of medical devices. The company also invests in research and development to expand its portfolio of products and services and ensure customer satisfaction. Overall, LifeTech Scientific Corp offers products and services in various medical divisions and strives for continuous development of new technologies and innovations to improve patient care. The company has earned an excellent reputation in the industry and always aims to meet the needs of its customers.

The expected revenue of LifeTech Scientific is 1.54 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of LifeTech Scientific is 277.40 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of LifeTech Scientific is currently 17.88. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the LifeTech Scientific stock.

The price-to-sales ratio (P/S) of LifeTech Scientific is currently 3.21. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the LifeTech Scientific stock.

The Eulerpool Quality Score for LifeTech Scientific is 6/10.

The ISIN of LifeTech Scientific is KYG548721177. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of LifeTech Scientific is A14M4J. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of LifeTech Scientific is 1302.HK. The ticker symbol is used to trade LifeTech Scientific shares on the stock exchange.

LifeTech Scientific paid dividends every year for the past 0 years.

LifeTech Scientific is assigned to the 'Health' sector.

The dividends of LifeTech Scientific are distributed in CNY.

Fair ValueTerminal
0.95 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
2.03 M CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CNY
Initial public offering
Nov 10, 2011
ISIN
KYG548721177
Cusip
G54872117
Sedol
BV9FKS0
Market capitalization
4.86 B CNYMid Cap
52-Week Range
1.11–2.11CNY
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
1.55
P/E ratio
P/Ee 2026
17.51
P/Ee 2027
15.01
P/Ee 2028
10.51
P/S
P/Se
3.21
EV/EBIT
18.44
P/B Ratio
1.19
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
4.20 %
Gross Margin
74.40 %
EBIT Margin
13.48 %
Net Margin
10.79 %
EPS (Earnings Per Share)
0.04 CNY
Net Debt / EBIT
-4.16
Debt/Equity
0.00
Last updated Sep 27, 2026, 11:56 AM

LifeTech Scientific Ticker

DÜSSELDORF · 81X.DUFRANKFURT · 81X.FHKEX · 1302.HKOTC · LFTSF

LifeTech Scientific FIGI

1302:HK · BBG0027G11B61302:H2 · BBG00F135KQ01302HKD:X2 · BBG00JZDMQ271302HKD:XB · BBG00JZDMQ361302HKD:XH · BBG00JZDMQ541302HKD:XF · BBG00JZDMQ721302HKD:XE · BBG00JZDMQ901302HKD:XJ · BBG00JZDMQB71302HKD:XL · BBG00JZDMQD51302HKD:XG · BBG00JZDMQF31302HKD:XO · BBG00JZDMQG21302HKD:XS · BBG00JZDMQL6